Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Abstract Text:

    keith norrisKeith Norris,jacque bourgoigneJacque Bourgoigne,jennifer gassmanJennifer Gassman,lee hebertLee Hebert,john middletonJohn Middleton,robert a phillipsRobert A Phillips,otelio randallOtelio Randall,stephen rostandStephen Rostand,susan shererSusan Sherer,robert d totoRobert D Toto,jackson t wrightJackson T Wright,xuelei wangXuelei Wang,tom greeneTom Greene,lawrence j appelLawrence J Appel,julia lewisJulia Lewis, ,

    BACKGROUND: Patients with chronic kidney disease are at increased risk for cardiovascular (CV) events. METHODS: We randomly assigned 1,094 African Americans with hypertensive nephrosclerosis (glomerular filtration rate [GFR], 20 to 65 mL/min/1.73 m(2) [0.33 to 1.08 mL/s]) to initial antihypertensive treatment with either: (1) a beta-blocker, metoprolol; (2) an angiotensin-converting enzyme inhibitor, ramipril; or (3) a dihydropyridine calcium channel blocker, amlodipine, and either a usual-blood pressure (BP) or low-BP treatment goal. Using a design powered to detect renal outcome differences, we compared the effect of treatment on the CV event rate (cardiac death, myocardial infarction, stroke, and heart failure) during a mean follow-up period of 4.1 years and determined baseline factors that predict CV outcomes. RESULTS: Thirty-one patients died of CV disease (0.7%/patient-year), and 149 patients experienced at least 1 CV outcome (3.3%/patient-year). Overall, 202 CV events (4.5%/patient-year) occurred. The CV outcome rate was not related significantly to randomized interventions. In multivariable analyses, 7 baseline risk factors remained independently associated with increased risk for the CV composite outcome after controlling for age, sex, baseline GFR, and baseline proteinuria group: pulse pressure, duration of hypertension, abnormal electrocardiogram result, non-high-density lipoprotein cholesterol level, serum urea nitrogen level, urine protein-creatinine ratio, urine sodium-potassium ratio, and annual income less than 15,000 dollars. CONCLUSION: Neither randomized class of antihypertensive therapy nor BP level had a significant effect on the occurrence of CV events, possibly because of limited power. However, this analysis identifies unique and potentially modifiable CV risk factors in this high-risk cohort.

    Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Publishing Authors By Initials

    k norrisK Norris,j bourgoigneJ Bourgoigne,j gassmanJ Gassman,l hebertL Hebert,j middletonJ Middleton,ra phillipsRA Phillips,o randallO Randall,s rostandS Rostand,s shererS Sherer,rd totoRD Toto,jt wrightJT Wright,x wangX Wang,t greeneT Greene,lj appelLJ Appel,j lewisJ Lewis, ,

    For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: American journal of kidney diseases : the official

    VOLUME: 48

    Page Numbers: 739-51

    Journal Abbreviation: Am. J. Kidney Dis.

    ISSN: 1523-6838

    DAY: 3

    MONTH: Nov

    YEAR: 2006

    Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8110075

    Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Keywords Mesh Terms:

    KEYWORDS: Risk Factors

    MESH TERMS: etiology

    Chemical & Substance for Abstract: Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Information

    Substance Name: Creatinine

    Registry Number: 60-27-5

    Grant and Affiliation Information for Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

    AFFILIATION: Charles R. Drew University of Medicine and Science, Lynwood, CA 90262, USA. knorris@ucla.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: P20-RR11145

    ACRONYM: RR

    MEDLINETA: Am J Kidney Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension AASK Trial Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News